Thank you to @FaltasLab and @urotoday for highlighting our hypothesis generating work evaluating enfortumab related skin toxicity and response in urothelial CA
Happy to share our comprehensive review on Enfortumab Vedotin. @JHBladderCancer@hopkinskimmel
Targeted Treatment of Locally Advanced and Metastatic Urothelial Cancer: Enfortumab Vedotin in Context https://t.co/ldxPsyzK8O
Thanks Dr San Chang @UroCancerMD and the team at UroToday for highlighting the care of patients with Upper Tract Urothelial Cancer and the importance of multidisciplinary care @SurenaMatinMD and Jonathan Coleman MD
Researchers @hopkinskimmel are conducting an immunotherapy+chemotherapy study for patients with localized invasive small cell #bladdercancer. For more information, including how to find out if you are eligible for the Small Cell Bladder Cancer Trial, visit
https://t.co/1bA33UVHyS